Round 2, 2022

• Hybrid genome assembly and annotation of Plasmodium vivax from the Asia-Pacific region
  Paolo Bareng, Deakin University

 

• Determining the degree of infant exposure to primaquine through colostrum and transitional breast milk – opening the gateway to early postpartum radical cure to curb maternal Plasmodium vivax relapse
  Dr Brioni Moore, Curtin University

 

• Predicting malaria transmissibility in a near elimination setting and identifying key drivers for malaria elimination
  Dr Kinley Wangdi, Australian National University

 

• Genomic surveillance for emerging Plasmodium knowlesi malaria
  Dr Jacob Westaway, Menzies School of Health Research

 

Round 1, 2022

• Defining the antigenic diversity of Plasmodium vivax apical membrane antigen-1 to inform vaccine development
  Dr Lee Yeoh, Burnet Institute

 

• A statistical framework for identifying sufficient data to infer a total parasite biomass
  Dr David Price, Doherty Institute, University of Melbourne

 

• Feasibility assessment of the use of Optical Mark Recognition around Vivax Malaria surveillance
  Dr Mary Malai, Papua New Guinea Institute of Medical Research

 

• Utilising community malaria volunteers to expand molecular and serological surveillance of malaria in pre-elimination settings
  Dr Win Han Oo, Burnet Institute

 

• Web-based interactive tool to improve decision-making for malaria elimination in Vietnam
  Dr Yalemzewod Gelaw, Curtin University and Telethon Kids Institute

 

• Collection of cells to isolate monoclonal antibodies to placental malaria antigens
  Dr Elizabeth Aitken, Doherty Institute, University of Melbourne

 

Round 2, 2021

• MinION sequencing for rapid detection of imported P. vivax cases
  Dr Marianna Kleinecke, Menzies School of Health Research

 

• Estimating disease prevalence in a sentinel site catchment population to complement case-based suveillance and develop decision-making tools
  Dr Diana Timbi, Papua New Guinea Institute of Medical Research

 

• Characterizing the longitudinal immune response to salivary antigens of Southeast Asian mosquito vectors of malaria, with a human challenge model
  Ms Ellen Kearney, Burnet Institute, Melbourne School of Population and Global Health

 

• Understanding cross-reactive antibodies in children without documented exposure to malaria
  Dr Rhea Longley, Walter and Eliza Hall Institute of Medical Research

 

• Artificial Intelligence-based drug resistance screening of malaria parasites using ‘Read Until’
  Dr Kirsty McCann, Deakin University

 

• Methodological comparison of P. vivax genotyping approaches for molecular surveillance within the ACREME network
  Dr Caitlin Bourke, Walter and Eliza Hall Institute of Medical Research

 

• Indentification of antibody targets and mechanisms associated with duration and spontaneous clearance of subclinical Plasmodium vivax infection
  Dr Katherine O’Flaherty, Burnet Institute

 

 

Round 1, 2021

• Spatial imaging and transcriptomic analysis of immune cells and malaria parasites in Plasmodium-infected human spleens
  Dr Steven Kho, Menzies School of Health Research

 

• Assessing the early development of functional antibody responses and target antigens in controlled human malaria infection to inform vaccine development
  Dr Linda Reiling, Burnet Institute

 

• Investigating asymptomatic transmission of malaria parasites in the Madang province of Papua New Guinea
  Dr Lincoln Timinao, Papua New Guinea Institute of Medical Research and Burnet Institute

 

 

Round 1, 2020

• Validating molecular and serological tools for detecting hidden reservoirs of Plasmodium infections in Papua New Guinea
  Dr Fiona Angrisano, Burnet Institute

 

• Investigating antibody responses to mosquito salivary antigens across the Asia Pacific to advance novel malaria surveillance strategies
  Dr Julia Cutts, Burnet Institute

 

• Understanding the role of polymorphisms in vaccine escape to guide malaria vaccine development and implementation
  Dr Liriye Kurtovic, Burnet Institute

 

• Optimal geospatial design of malaria surveillance programs
  Dr Freya Shearer, University of Melbourne

 

• Serological exposure markers for P. vivax in pregnant women
  Dr Holger Unger, Menzies School of Health Research

 

• Characterizing antibody responses to PfEMP1 as biomarkers of severe and uncomplicated malaria in Papua New Guinea
  Dr Isobel Walker, University of Melbourne

 

Round 2, 2019

• How best can we detect the hidden splenic parasite biomass in human Plasmodium infection? Part 1: peripheral blood
  Dr Steven Kho, Menzies School of Health Research

 

• Age-dependent diversity of innate immune responses in malaria
  Dr Jessica Loughland, QIMR Berghofer Medical Research Institute

 

• Use of proteomics as a platform for evaluating new biomarkers for improving diagnosis of Plasmodium vivax for the purpose of malaria elimination
  Dr Sumudu Britton, QIMR Berghofer Medical Research Institute

 

• Investigating the transmissibility of artemisinin-resistant P. falciparum and the effect of artesunate on gametocyte production
  Dr Zuleima Pava, QIMR Berghofer Medical Research Institute

 

Round 1, 2019

• Field evaluation of a Point-of-Contact device for P. falciparum malaria serosurveillance
  Dr Aung Pyae Phyo, Burnet Institute

 

• Functional human antibodies that target P. falciparum gametocytes to reduce malaria transmission
  Dr Jo-Anne Chan, Burnet Institute

 

• The impact of a malaria infection on G6PD activity (MAGY)
  Dr Benedikt Ley, Menzies School of Health Research

 

• Building capacity for an innovative amplicon deep sequencing tool to genotype Plasmodium infections for improved surveillance
  Dr Shazia Ruybal Pesántez, Walter and Eliza Hall Institute of Medical Research

 

• Development of a high-sensitivity reader for improving use of malaria RDTs
  Dr Leanna Surrao, Burnet Institute

 

Round 2, 2018

• Enhanced geospatial surveillance for identifying malaria transmission hotspots using antenatal screening in PNG
  Dr Ricardo Ataide, Burnet Institute

 

• Development of a novel mouse model of artemisinin-resistant malaria to screen and prioritize antimalarial drugs effective against artemisinin-resistant parasites
  Dr Maria Rebelo, QIMR Berghofer Medical Research Institute

 

• Paving the way for universal radical cure
  Dr Kamala Thriemer, Menzies School of Health Research

 

Round 1, 2018

• The cost-effectiveness of molecular epidemiology to inform malaria control program decision-making: a scoping exercise.
  Dr Angela Devine, Burnet Institute

 

• Understanding RTS,S immunity to inform vaccine implementation and design an improved pre-erythrocyte stage vaccine to facilitate malaria elimination
  Dr Gaoqian Feng, Burnet Institute

 

• Novel serological markers for surveillance of both P. vivax malaria exposure and immunity
  Dr Rhea Longley, Walter and Eliza Hall Institute of Medical Research

 

• Developing a multiscale model combining both within-host and population level information to predict the emergence and spread of antimalarial resistance
  Dr Pengxing Cao, University of Melbourne